KRRO stock news

KRRO stock news. Deduplicated factual headlines, scored for importance, with entity sentiment and the sectors, countries, and asset classes affected. Updates open into the storyline.

See the full wire

8 wire items

2026-10-20 19:26:17 UTC#488614newconfirmednews

Korro Bio sets 2027 Rinvatercept data readout and 2028-2029 Eleriscept timeline

quartrimportance 0.40trust 0.60Korro Bio, Inc. +0.20Takeda Pharmaceutical Company Limited +0.30Rinvatercept +0.20+1 entities

2026-10-20 14:26:28 UTC#487050newconfirmednews

Korro Bio targets H2 2027 data for KRRO-121; Tevard Biosciences eyes clinical entry by early 2028

quartrimportance 0.30trust 0.60Korro Bio, Inc. +0.30Tevard Biosciences, Inc. +0.30KRRO-121 +0.30

2026-10-06 10:26:00 UTC#418612newconfirmednews

H.C. Wainwright maintains $15.00 price target on Korro Bio

dow_jonesimportance 0.30trust 0.70Korro Bio, Inc. +0.10H.C. Wainwright & Co., LLC +0.10

2026-10-05 21:31:08 UTC#416176duplicateconfirmednews

Korro Bio confirms first cohort dosed in Phase 1/2 ANCHOR trial for KRRO-121

reutersimportance 0.30trust 0.80Korro Bio, Inc. +0.30KRRO-121 +0.30ANCHOR +0.30

2026-10-05 20:13:01 UTC#415717newconfirmednews

Korro Bio initiates Phase 1/2 ANCHOR trial of KRRO-121 with first 2 mg/kg dose in healthy volunteers

tradingviewimportance 0.40trust 0.80Korro Bio, Inc. +0.30KRRO-121 +0.30ANCHOR +0.20

2026-08-20 11:49:00 UTC#200510newconfirmednews

H.C. Wainwright & Co. maintains $15.00 price target on Korro Bio

dow_jonesimportance 0.30trust 0.60Korro Bio, Inc. 0H.C. Wainwright & Co., LLC 0

2026-08-07 16:24:19 UTC#146236newforecastnews

Korro Bio (KRRO) Q3 2026 Earnings Preview: Analysts Forecast $1.43 Loss Per Share and $214K Revenue

reutersimportance 0.30trust 0.80Korro Bio, Inc. -0.30London Stock Exchange Group plc 0

2026-08-06 12:26:41 UTC#137203newconfirmeddata release

Korro Bio reports Q2 2026 GAAP EPS of -$1.07 and revenue of $1.5M

seeking alphaimportance 0.30trust 0.80Korro Bio, Inc. -0.10